Cargando…
Programmed Cell Death Protein 1 (PD-1) Molecule in Coronavirus Disease 2019 (COVID-19)?
Autores principales: | Mortaz, Esmaeil, Jamaati, Hamidreza, Varahram, Mohammad, Dezfuli, Neda K., Adocok, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355930/ https://www.ncbi.nlm.nih.gov/pubmed/34394361 |
Ejemplares similares
-
Is There an Ending in Insight for COVID-19?
por: Mortaz, Esmaeil, et al.
Publicado: (2021) -
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
por: Mortaz, Esmaeil, et al.
Publicado: (2021) -
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
por: Mortaz, Esmaeil, et al.
Publicado: (2021) -
T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions
por: Roofchayee, Neda Dalil, et al.
Publicado: (2021) -
Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients
por: Kiaee, Fatemeh, et al.
Publicado: (2022)